Atwater Malick LLC

Position in LLY — ELI LILLY & Co

CIK 1769288 LANCASTER, PA

Position in LLY

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,217,421

+$373,073 QoQ

Shares Held

1,015

+10.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#2,950

of 4,605 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Atwater Malick LLC holds $12,919,723 across 8 Drug Manufacturers - General names. LLY ranks #3 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	27,778	$7,054,778
2	NVO	Novo Nordisk A S	57,670	$2,764,699
3	LLY	ELI LILLY & Co This page	1,015	$1,217,421
4	ABBV	AbbVie Inc.	3,342	$840,980
5	MRK	Merck & Co., Inc.	2,527	$324,719
6	GILD	Gilead Sciences, Inc.	2,245	$283,633
7	AMGN	Amgen Inc	644	$233,205
8	NVS	Novartis AG	1,278	$200,288

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,217,421	1,015	+10.6%	Shares	Sole	2026-07-27
2026-03-31	$844,348	918	-10.2%	Shares	Sole	2026-04-22
2025-12-31	$1,098,323	1,022	+0.4%	Shares	Sole	2026-01-23
2025-09-30	$776,734	1,018	+1.3%	Shares	Sole	2025-10-23
2025-06-30	$783,427	1,005	0.0%	Shares	Sole	2025-07-21
2025-03-31	$830,039	1,005	-2.0%	Shares	Sole	2025-04-11
2024-12-31	$791,300	1,025	+14.9%	Shares	Sole	2025-01-15
2024-09-30	$790,258	892	0.0%	Shares	Sole	2024-10-10
2024-06-30	$807,598	892	0.0%	Shares	Sole	2024-07-17
2024-03-31	$693,940	892	0.0%	Shares	Sole	2024-04-16
2023-12-31	$519,964	892	0.0%	Shares	Sole	2024-01-11
2023-09-30	$479,119	892	0.0%	Shares	Sole	2023-10-17
2023-06-30	$418,330	892	—	Shares	Sole	2023-07-17
No filing history on record for this holder in this stock.